Other subjects - OPEN Foundation

Effective connectivity changes in LSD-induced altered states of consciousness in humans

Preller, K. H., Razi, A., Zeidman, P., Stämpfli, P., Friston, K. J., & Vollenweider, F. X. | Proceedings of the National Academy of Sciences | 12 February 2019

Long-lasting analgesic effect of the psychedelic drug changa: A case report

Ona, G., & Troncoso, S. | Journal of Psychedelic Studies |12 February 2019

Greater empathy in MDMA users

Carlyle, M., Stevens, T., Fawaz, L., Marsh, B., Kosmider, S., & Morgan, C. J. | Journal of Psychopharmacology | 5 February 2019

Metabolite Profiling of Antiaddictive Alkaloids from Four Mexican Tabernaemontana Species and the Entheogenic African Shrub Tabernanthe iboga (Apocynaceae)

Krengel, F., Chevalier, Q., Dickinson, J., Santoyo, J. H., & Reyes-Chilpa, R. | Chemistry & biodiversity | 7 January 2019

The effects of ketamine on suicidality across various formulations and study settings

Dadiomov, D., & Lee, K. | Mental Health Clinician | 4 January 2019

How do psychedelics work?

Carhart-Harris, R. L. | Current opinion in psychiatry | 1 January 2019

Role of serotonin transporter and receptor gene variations in the acute effects of MDMA in healthy subjects

Vizeli, P., Meyer zu Schwabedissen, H. E., & Liechti, M. E. | ACS chemical neuroscience | 27 December 2018

DARK Classics in Chemical Neuroscience: Atropine, Scopolamine, and Other Anticholinergic Deliriant Hallucinogens

Lakstygal, A., Kolesnikova, T., Khatsko, S., Zabegalov, K., Volgin, A., Demin, K., & Kalueff, A. | ACS chemical neuroscience | 19 December 2018

Psychiatry might need some psychedelic therapy

Johnson, M. W. | International Review of Psychiatry | 3 December 2018

Monoamine biosynthesis via a noncanonical calcium-activatable aromatic amino acid decarboxylase in psilocybin mushroom

Torrens-Spence, M. P., Liu, C. T., Pluskal, T., Chung, Y. K., & Weng, J. K. | ACS chemical biology | 28 November 2018

Self-Experiments with Psychoactive Substances: A Historical Perspective

Passie, T., & Brandt, S. D. | Handbook of Experimental Pharmacology | 27 November 2018

Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions

Garcia-Romeu, A., & Richards, W. A. | International Review of Psychiatry | 13 November 2018

Neuroimaging of chronic MDMA (“ecstasy”) effects: A meta-analysis

Müller, F., Brändle, R., Liechti, M. E., & Borgwardt, S. | Neuroscience & Biobehavioral Reviews | 12 November 2018

What Psilocybin Taught Me About Dying

Back, A. L. | Journal of palliative medicine | 9 November 2018

Predicting Responses to Psychedelics: A Prospective Study

Haijen, E. C. H. M., Kaelen, M., Roseman, L., Timmermann, C., Russ, S., Nutt, D., ... & Carhart-Harris, R. L. | Frontiers in pharmacology | 2 November 2018

Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor

Preller, K. H., Burt, J. B., Ji, J. L., Schleifer, C. H., Adkinson, B. D., Stämpfli, P., & Vollenweider, F. X. | eLife | 25 October 2018

Psychedelic Moral Enhancement

Earp, B. D. | Royal Institute of Philosophy Supplements | 16 October 2018

Research ethics aspects of experimentation with LSD on human subjects: a historical and ethical review.

Bodnár, K. J., & Kakuk, P. | Medicine, Health Care and Philosophy | 16 October 2018

Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents.

Kivell, B., Paton, K., Kumar, N., Morani, A., Culverhouse, A., Shepherd, A., ... & Prisinzano, T. | Molecules | 11 October 2018

The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug

Jalal, B. | Psychopharmacology | 5 October 2018

Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain.

Müller, F., Liechti, M. E., Lang, U. E., Borgwardt, S., Wilson, M. R., Webb, A., ... & Lutz, K. | Progress in brain research | 28 September 2018